(2026). Inhibition of ERN1 suppresses the expression of phosphoenolpyruvate carboxykinase 2 in U87MG glioblastoma cells and increases its sensitivity to glucose and glutamine deprivation. Endocrine Regulations.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Inhibition of ERN1 Suppresses the Expression of Phosphoenolpyruvate Carboxykinase 2 in U87MG Glioblastoma Cells and Increases Its Sensitivity to Glucose and Glutamine Deprivation."
Endocrine Regulations 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Inhibition of ERN1 Suppresses the Expression of Phosphoenolpyruvate Carboxykinase 2 in U87MG Glioblastoma Cells and Increases Its Sensitivity to Glucose and Glutamine Deprivation."
Endocrine Regulations, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.